CFTR and cystic fibrosis: Even more impressive, improvement of GI symptoms was observed in CF patients treated with orkambi, the combination of the CFTR corrector lumacaftor and the potentiator IVA, which was recently approved for CF patients homozygous for F508del in many countries.